{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:42:56Z","timestamp":1772808176987,"version":"3.50.1"},"reference-count":25,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,6]]},"abstract":"<jats:p content-type=\"fine-print\"><jats:italic>Object.<\/jats:italic> A synthetic heterocyclic pyrimidine compound, MS-818 (2-piperadino-6-methyl-5-oxo-5,6-dihydro-(7H) pyrrolo-[3,4-d] pyrimidine maleate) is reported to have a variety of biological activities including neurite outgrowth, astrocyte differentiation, suppression of neuronal apoptosis, regeneration of injured peripheral nerves, fracture repairs, angiogenesis, and superovulation. To be able to explicate the neurotrophic effects of MS-818, the authors evaluated its effect on the reduction of infarct volume and amelioration of sensorimotor dysfunction in a rat model of focal ischemia.<\/jats:p>\n<jats:p content-type=\"fine-print\"><jats:italic>Methods.<\/jats:italic> Forty male Sprague\u2014Dawley rats were subjected to right middle cerebral artery occlusion and assigned to one of four treatment groups (10 animals in each group). The MS-818 (1, 5, or 10 mg\/kg) or phosphate-buffered saline (control group) was administered intraperitoneally at onset of ischemia and again 24 hours later. The rats were killed 48 hours after they underwent surgery to induce stroke, and infarct volume was determined using an image-analysis computer software program following staining with 2,3,5-triphenyltetrazolium chloride. Postischemic neurological deficit and body weight were also assessed.<\/jats:p>\n<jats:p content-type=\"fine-print\"><jats:italic>Conclusions.<\/jats:italic> Significant reductions in infarct volume (total and cortical infarction) were found in all the MS-818\u2014treated groups compared with the control group. Furthermore, MS-818 induced significant amelioration of sensorimotor dysfunction, as indicated by the results of forelimb and hindlimb placing tests. The present findings suggest that MS-818, which has a much smaller molecular weight than neurotrophic peptides, represents a new approach to the treatment of focal cerebral ischemia.<\/jats:p>","DOI":"10.3171\/jns.2002.96.6.1072","type":"journal-article","created":{"date-parts":[[2009,5,13]],"date-time":"2009-05-13T17:44:46Z","timestamp":1242236686000},"page":"1072-1076","source":"Crossref","is-referenced-by-count":12,"title":["Role of a synthetic pyrimidine compound, MS-818, in reduction of infarct size and amelioration of sensorimotor dysfunction following permanent focal cerebral ischemia in rats"],"prefix":"10.3171","volume":"96","author":[{"given":"Tetsuryu","family":"Mitsuyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takakazu","family":"Kawamata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumitaka","family":"Yamane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Awaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomokatsu","family":"Hori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1","series-title":"Biol Pharm Bull","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1248\/bpb.16.248","article-title":"Neurotropic pyrimidine heterocyclic compounds. I. The newly synthesized pyrimidine compounds promote neurite outgrowth of GOTO and neuro 2a neuroblastoma cell lines, and potentiate nerve growth factor (NGF)-induced neurite sprouting of PC 12 cells.","volume":"16","author":"Awaya","year":"1993"},{"key":"b2","series-title":"J Cell Biol","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1083\/jcb.115.2.461","article-title":"Aurintricarboxylic acid rescues PC12 cells and sympathetic neurons from cell death caused by nerve growth factor deprivation: correlation with suppression of endonuclease activity.","volume":"115","author":"Batistatou","year":"1991"},{"key":"b3","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1161\/01.STR.17.3.472","article-title":"Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.","volume":"17","author":"Bederson","year":"1986"},{"key":"b4","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/0006-8993(92)90112-M","article-title":"Neocortical localization of tactile\/proprioceptive limb placing reactions in the rat.","volume":"573","author":"De Ryck","year":"1992"},{"key":"b5","series-title":"J Cereb Blood Flow Metab","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/jcbfm.1995.121","article-title":"Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats.","volume":"15","author":"Fisher","year":"1995"},{"key":"b6","series-title":"Restor Neurol Neurosci","first-page":"9","article-title":"A synthesized pyrimidine compound, MS-818, promotes walking function recovery from crush injury of the sciatic nerve through its indirect stimulation of Schwann cells.","volume":"17","author":"Fukuyama","year":"2000"},{"key":"b7","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1161\/01.STR.27.9.1657","article-title":"Automated measurement of infarct size with scanned images of triphenyltetrazolium chloride-stained rat brains.","volume":"27","author":"Goldlust","year":"1996"},{"key":"b8","series-title":"Brain Res Mol Brain Res","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0169-328X(00)00043-7","article-title":"Differential activation of MAPK\/ERK and p38\/SAPK in neurones and glia following focal cerebral ischaemia in the rat.","volume":"77","author":"Irving","year":"2000"},{"key":"b9","series-title":"Restor Neurol Neurosci","first-page":"265","article-title":"The effect of neurotrophic pyrimidine heterocyclic compounds, MS-818 and MS-430, on the regeneration of injured peripheral nerves.","volume":"14","author":"Itoh","year":"1999"},{"key":"b10","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/BF00294311","article-title":"The effect of MS-818, a pyrimidine compound, on the regeneration of peripheral nerve fibers of mice after a crush injury.","volume":"90","author":"Jiang","year":"1995"},{"key":"b11","series-title":"J Cereb Blood Flow Metab","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/00004647-199607000-00003","article-title":"Intracisternal basic fibroblast growth factor (bFGF) enhances behavioral recovery following focal cerebral infarction in the rat.","volume":"16","author":"Kawamata","year":"1996"},{"key":"b12","series-title":"Proc Natl Acad Sci USA","doi-asserted-by":"publisher","first-page":"8179","DOI":"10.1073\/pnas.94.15.8179","article-title":"Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction.","volume":"94","author":"Kawamata","year":"1997"},{"key":"b13","series-title":"Exp Neurol","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1006\/exnr.1999.7101","article-title":"Intracisternal antisense oligonucleotide to growth associated protein-43 blocks the recovery-promoting effects of basic fibroblast growth factor after focal stroke.","volume":"158","author":"Kawamata","year":"1999"},{"key":"b14","series-title":"Brain Plasticity. Advances in Neurology.","first-page":"377","article-title":"The role of polypeptide growth factors in recovery from stroke","volume":"73","author":"Kawamata","year":"1997"},{"key":"b15","series-title":"Biol Pharm Bull","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1248\/bpb.20.138","article-title":"Neurotropic pyrimidine heterocyclic compounds. II. Effects of novel neurotropic pyrimidine derivatives on astrocytic morphological differentiation.","volume":"20","author":"Koyama","year":"1997"},{"key":"b16","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0006-8993(00)03228-5","article-title":"SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia.","volume":"892","author":"Legos","year":"2001"},{"key":"b17","series-title":"J Reprod Dev","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1262\/jrd.43.137","article-title":"Enhancement of number of ovulations by administration of a pyrimidine compound with potentiating activity of angiogenesis in mice super-ovulated by PMSG and hCG.","volume":"43","author":"Matsumoto","year":"1997"},{"key":"b18","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"16464","DOI":"10.1074\/jbc.270.27.16464","article-title":"A neuroprotective compound, aurin tricarboxylic acid, stimulates the tyrosine phosphorylation cascade in PC12 cells.","volume":"270","author":"Okada","year":"1995"},{"key":"b19","series-title":"The Rat Brain in Stereotaxic Coordinates.","author":"Paxinos","year":"1986"},{"key":"b20","series-title":"Cell Regul","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1091\/mbc.2.5.383","article-title":"Carbachol stimulates a different phospholipid metabolism than nerve growth factor and basic fibroblast growth factor in PC12 cells.","volume":"2","author":"Pessin","year":"1991"},{"key":"b21","series-title":"J Neurosci Res","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/(SICI)1097-4547(19981201)54:5<604::AID-JNR5>3.0.CO;2-W","article-title":"A novel neurotrophic pyrimidine compound MS-818 enhances neurotrophic effects of basic fibroblast growth factor.","volume":"54","author":"Sanjo","year":"1998"},{"key":"b22","series-title":"J Cereb Blood Flow Metab","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/jcbfm.1990.47","article-title":"A semiautomated method for measuring brain infarct volume.","volume":"10","author":"Swanson","year":"1990"},{"key":"b23","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0006-8993(97)01491-1","article-title":"A newly synthesized neurotropic pyrimidine compound, MS-818, may activate migratory schwann cells in peripheral nerve regeneration.","volume":"787","author":"Torigoe","year":"1998"},{"key":"b24","series-title":"J Neurosci","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1523\/JNEUROSCI.17-01-00083.1997","article-title":"Pituitary adenylate cyclaseactivating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway.","volume":"17","author":"Villalba","year":"1997"},{"key":"b25","series-title":"Int J Clin Pharmacol Res","first-page":"167","article-title":"The neurotrophic pyrimidine heterocyclic compound MS-818 promotes the angiogenesis induced by basic FGF.","volume":"15","author":"Yasuhara","year":"1995"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/96\/6\/article-p1072.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/96\/6\/article-p1072.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/96\/6\/article-p1072.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T21:41:34Z","timestamp":1679866894000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/96\/6\/article-p1072.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":25,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3171\/jns.2002.96.6.1072","relation":{},"ISSN":["0022-3085"],"issn-type":[{"value":"0022-3085","type":"print"}],"subject":[],"published":{"date-parts":[[2002,6]]}}}